Quarterly report pursuant to Section 13 or 15(d)

12. SEGMENTS

v3.19.2
12. SEGMENTS
3 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
SEGMENTS

12. SEGMENTS

 

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and Exosome Sciences, Inc., or ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

     

The following tables set forth certain information regarding our segments:

 

    Three Months Ended June 30,  
    2019     2018  
Revenues:                
Aethlon   $ 30,000     $ 149,625  
ESI            
Total Revenues   $ 30,000     $ 149,625  
                 
Operating Losses:                
Aethlon   $ (1,561,885 )   $ (1,066,530 )
ESI     (4,303 )     (30,742 )
Total Operating Loss   $ (1,566,188 )   $ (1,097,272 )
                 
Net Losses:                
Aethlon   $ (2,062,981 )   $ (1,121,634 )
ESI     (4,303 )     (30,742 )
Net Loss Before Non-Controlling Interests   $ (2,067,284 )   $ (1,152,376 )
                 
Cash:                
Aethlon   $ 2,492,170     $ 6,120,796  
ESI     184       2,106  
Total Cash   $ 2,492,354     $ 6,122,902  
                 
Total Assets:                
Aethlon   $ 2,932,721     $ 6,451,635  
ESI     184       2,106  
Total Assets   $ 2,932,905     $ 6,453,741  
                 
Capital Expenditures:                
Aethlon   $ 886     $  
ESI            
Capital Expenditures   $ 886     $  
                 
Depreciation and Amortization:                
Aethlon   $ 2,868     $ 8,109  
ESI            
Total Depreciation and Amortization   $ 2,868     $ 8,109  
                 
Interest Expense:                
Aethlon   $ (54,085 )   $ (55,104 )
ESI            
Total Interest Expense   $ (54,085 )   $ (55,104 )